FDA Slaps Osiris For Misleading Medical Claims About Stem-Cell Bandage – TheStreet.com
|
FDA Slaps Osiris For Misleading Medical Claims About Stem–Cell Bandage
TheStreet.com COLUMBIA, Md. (TheStreet) — The U.S. Food and Drug Administration has told Osiris Therapeutics ( (OSIR) ) to stop making unproven medical claims about its Grafix “stem cell” band-aid healing diabetic foot ulcers, according to a warning letter sent to … Osiris and FDA Reach Agreement on Regulatory Pathway for Biosurgery ProductsMarketWatch Osiris Reaches Agreement with FDA Over Regulatory Status for Grafix, OvationWall Street Journal |
